A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vasoocclusive Crises
2022-11-21
عنوان الدراسة
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vasoocclusive Crises
داعم الدراسة
Global Blood Therapeutics, Inc.
دواء الدراسة
Inclacumab
رقم بروتوكول الدراسة
GBT2104-131
حالة الدراسة
Ongoing
موقع الدراسة
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia , Qatif Central Hospital
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。